Total Payments
$26,432
2023 Payments
$11,457
Companies
4
Transactions
44
Medicare Patients
1,315
Medicare Billing
$106,422
Payment Breakdown by Category
Consulting$15,979 (60.5%)
Other$7,575 (28.7%)
Travel$1,955 (7.4%)
Food & Beverage$923.02 (3.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,979 | 3 | 60.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,200 | 3 | 27.2% |
| Travel and Lodging | $1,955 | 25 | 7.4% |
| Food and Beverage | $923.02 | 12 | 3.5% |
| Honoraria | $375.00 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $14,805 | 6 | $0 (2018) |
| BioXcel Therapeutics, Inc. | $11,457 | 36 | $0 (2023) |
| Konica Minolta Healthcare Americas, Inc | $115.44 | 1 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $53.84 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $11,457 | 36 | BioXcel Therapeutics, Inc. ($11,457) |
| 2022 | $53.84 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($53.84) |
| 2019 | $115.44 | 1 | Konica Minolta Healthcare Americas, Inc ($115.44) |
| 2018 | $4,770 | 1 | Gilead Sciences, Inc. ($4,770) |
| 2017 | $10,035 | 5 | Gilead Sciences Inc ($10,035) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $115.59 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Honoraria | Cash or cash equivalent | $375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,420.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $66.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $36.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $28.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $10.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $10.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/27/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $10.79 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $215.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $215.74 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Consulting Fee | Cash or cash equivalent | $1,440.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $344.99 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $103.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $97.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $49.45 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $49.45 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $311.12 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $306.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $129.88 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $97.24 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $5.04 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $17.50 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 297 | 297 | $117,283 | $26,242 |
| 2022 | 8 | 312 | 316 | $112,006 | $27,341 |
| 2021 | 10 | 379 | 386 | $110,991 | $28,452 |
| 2020 | 12 | 327 | 330 | $109,108 | $24,388 |
Total Patients
1,315
Total Services
1,329
Medicare Billing
$106,422
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 71 | 71 | $34,530 | $6,924 | 20.1% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 48 | 48 | $34,032 | $6,768 | 19.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 67 | $17,085 | $4,761 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 28 | $10,332 | $3,050 | 29.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $7,898 | $1,835 | 23.2% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 21 | 21 | $5,586 | $1,068 | 19.1% |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | Office | 2023 | 11 | 11 | $4,719 | $1,033 | 21.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 14 | 14 | $2,576 | $703.92 | 27.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 15 | 15 | $525.00 | $100.35 | 19.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 67 | 68 | $48,212 | $10,669 | 22.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 83 | $21,165 | $6,316 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 36 | 36 | $13,284 | $4,095 | 30.8% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 21 | 21 | $10,248 | $2,085 | 20.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $10,052 | $2,076 | 20.7% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 19 | 19 | $5,054 | $1,031 | 20.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 16 | $2,416 | $766.14 | 31.7% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 44 | 45 | $1,575 | $302.85 | 19.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 60 | 60 | $42,540 | $9,468 | 22.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 93 | 98 | $23,775 | $7,613 | 32.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 36 | 36 | $12,468 | $3,257 | 26.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 20 | 20 | $9,760 | $1,971 | 20.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 39 | 39 | $5,567 | $1,779 | 32.0% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 23 | 23 | $5,463 | $1,622 | 29.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 14 | $4,956 | $1,428 | 28.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 17 | 17 | $4,522 | $944.19 | 20.9% |
About Dr. Gary Vilke, MD
Dr. Gary Vilke, MD is a Emergency Medicine healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922042779.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Vilke, MD has received a total of $26,432 in payments from pharmaceutical and medical device companies, with $11,457 received in 2023. These payments were reported across 44 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($15,979).
As a Medicare-enrolled provider, Vilke has provided services to 1,315 Medicare beneficiaries, totaling 1,329 services with total Medicare billing of $106,422. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location San Diego, CA
- Active Since 06/15/2006
- Last Updated 02/02/2019
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1922042779
Products in Payments
- IGALMI (Drug) $11,457
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in San Diego
Dr. Paul Pearigen, M.d, M.D
Emergency Medicine — Payments: $199,890
Emergency Medicine $199,890
Bradley Bailey, M.d, M.D
Emergency Medicine — Payments: $107,154
Emergency Medicine $107,154
Dr. Christopher Coyne, M.d, M.D
Emergency Medicine — Payments: $89,371
Emergency Medicine $89,371
Dr. Michael Nielsen, Md, MD
Emergency Medicine — Payments: $49,172
Emergency Medicine $49,172
Andrew Desjardins, M.d, M.D
Emergency Medicine — Payments: $42,260
Emergency Medicine $42,260
Dr. Rodney Sidransky, Md, MD
Emergency Medicine — Payments: $9,410
Emergency Medicine $9,410